Quest Partners LLC Biomarin Pharmaceutical Inc Transaction History
Quest Partners LLC
- $1.53 Trillion
- Q3 2025
A detailed history of Quest Partners LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Quest Partners LLC holds 13,460 shares of BMRN stock, worth $736,665. This represents 0.05% of its overall portfolio holdings.
Number of Shares
13,460
Previous 35,156
61.71%
Holding current value
$736,665
Previous $1.93 Billion
62.28%
% of portfolio
0.05%
Previous 0.19%
Shares
6 transactions
Others Institutions Holding BMRN
# of Institutions
664Shares Held
182MCall Options Held
1.48MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.24 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.2MShares$833 Million0.65% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$804 Million0.46% of portfolio
-
State Street Corp Boston, MA8.76MShares$480 Million0.02% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...